Immunology Club Seminar Series 2007 to present
DC 1/14/2020 Immunology Club Seminar Series 2007-Present Date Seminar Title Speaker Name Speaker Affiliation ...
Immunosuppression Drugs May Reduce COVID-19 Vaccine Response
NYU Langone surgery chair Dr. Robert Montgomery, a heart transplant recipient, had no COVID-19 antibodies after two vaccine doses.
Immunotherapy Adds Punch to Past Treatments for Lymphoma
NYU Langone study shows immunotherapy may “sensitize” patients with lymphoma to better respond to medications that did not initially work well.
Immunotherapy After Surgery Could Prevent Return of Melanoma
Dr. Janice Mehnert, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses potential immunotherapy treatment for melanoma.
Immunotherapy Approved as First Treatment for Stomach Cancer
Medical oncologist Dr. Paul E. Oberstein, a member of NYU Langone’s Perlmutter Cancer Center, discusses a new strategy to treat stomach cancer.
Immunotherapy Cancer Expert Joins NYU Langone
Immunotherapy and melanoma expert Jeffrey S. Weber, MD, PhD, joins the senior leadership team at NYU Langone’s Perlmutter Cancer Center.
Immunotherapy Clinical Trial Gives Hope for Rare Skin Cancer
A participant in an immunotherapy clinical trial offered by NYU Langone’s Perlmutter Cancer Center shares her experience.
Immunotherapy Does Not Increase Risk for Prostate Cancer
Transplant recipients can be safely screened and managed for prostate cancer under general guidelines, reports NYU Langone’s Dr. Herbert Lepor.
Immunotherapy Drug Proves Effective for Treating Melanoma
NYU Langone’s Dr. Jeffrey Weber explains to CBS News how one immunotherapy drug is better than another in treating advanced melanoma.
Immunotherapy Helps Lung Cancer Patients Live Longer
NYU Langone researcher Dr. Leena Gandhi leads a study suggesting immunotherapy should be the new standard of care to treat lung cancer.